Our results demonstrate that exogenous SELENOV downregulated TXNRD1 and TXNRD3 mRNA expression, which may represent an important anticancer effect since both enzymes are frequent pharmacological targets in various cancer therapies [37,38,39]. Here, TXNRD3 is linked to cancer.